Directory

Text:
Increase font size
Decrease font size
swift-scanlan

Theresa Swift-Scanlan, PhD, MS, BSN, BS, RN

Assistant Professor

The University of North Carolina at Chapel Hill
School of Nursing
Carrington Hall, CB #7460
Chapel Hill, NC 27599-7460

Office: 503

Phone: (919) 966-1806

Email: tswift@email.unc.edu

Specialty Area: Adult Health

Biography

Theresa Swift-Scanlan began her career with a B.S. and M.S. in Molecular Biology and trained in applied marine sciences research facilities in Norfolk and Baltimore. This work focused mainly on environmental and microbiome studies of marine sponges with novel anti-cancer compounds. She entered nursing following a two year tour of duty in the United States Peace Corps, graduating with her BSN and PhD from the Johns Hopkins University School of Nursing. Dr. Swift-Scanlan has worked extensively on the genetic and epigenetic underpinnings of multifactorial conditions including; affective disorders, depression, and addiction, with a current emphasis on breast cancer. Swift-Scanlan Laboratory Room 013, Carrington Hall

Selected Publications (17 of 30)

For Theresa Swift-Scanlan (formerly Theresa S. Breschel) *Denotes senior or corresponding author dbDenotes databased publication
  • Stolzenburg, S., Beltran, A., Swift-Scanlan, T., Rivenbark, A., & Blancafort, P.(2014). Stable inherited oncogenic silencing in vivo by programmable and targeted de novo DNA Methylation in Breast Cancer. Oncogene. In Review, 2014. db
  • Rattani N.S., & T.Swift-Scanlan (2014). Deconstructing breast cancer heterogeneity: Clinical implications for women with basal-like tumors. Oncology Nursing Forum. In Press, 2014. *
  • Conway, K., Edmiston, S.N., May, R., Kuan, P.F., Chu, H., Bryant, C., Swift-Scanlan, T., Troester, M.A.,  Geradts, J., & Millikan, R.C. (2014). DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival. Breast Cancer research. In Press, 2014.db
    1. Swift-Scanlan, T., Smith, C.T., Bardowell, S.A., & Boettiger, C.A. (2014). Comprehensive interrogation of CpG islands in the gene encoding COMT, a key estrogen and catecholamine regulator. BMC Medical Genomics. 2014;7(5):1-14.  PMID:24460628 db*
    2. Bardowell, S.A., Parker, J.S., Fan, C., Crandell, J., Perou, C.M., & Swift-Scanlan, T.Differential methylation relative to breast cancer subtype and matched normal tissue reveals distinct patterns. Breast Cancer Research and Treatment. 2013;142(2):365-80. PMID: 2421271 db*
    3. Smith, C.T., Swift-Scanlan, T., & Boettiger, C.A. Genetic polymorphisms regulating dopamine signaling in the frontal cortex interact to affect target detection under high working memory load. Journal of Cognitive Neuroscience. 201; 26(2):395-407. PMID: 24144248 db
    4. Ulirsch J, Fan C, Knafl G, Wu MJ, Coleman B, Perou CM, Swift-Scanlan T. Vimentin DNA methylation predicts survival in breast cancer. Breast Cancer Research and Treatment. 2013;137(2):383-96. PMID:23239149 db*
    5. Swift-Scanlan T., Vang R, Blackford A, Fackler MJ, Sukumar S. Methylated genes in breast cancer: Associations with clinical and histopathological features in a familial breast cancer cohort. Cancer Biology & Therapy. 2011; 11(10): 1-13. PMID: 21383541 db*
    6. Troester MA, Swift-Scanlan T. Challenges in studying the etiology of breast cancer subtypes. Breast Cancer Research. 2009; 11(3):104. PMID:19635173
    7. Fackler MJ, Malone K, Zhang Z, Schilling E, Garrett-Mayer E, Swift-Scanlan T, Lange J, Nayar R, Davidson NE, Khan SA, Sukumar S. Quantitative Multiplex Methylation-Specific PCR Analysis Doubles Detection of Tumor Cells in Breast Ductal Fluid. Clinical Cancer Research 2006. 12: 3306-3310. db
    8. Swift-Scanlan T, Blackford A, Argani P, Sukumar S, Fackler MJ. Two color Quantitative Multiplex Methylation Specific PCR. Biotechniques 2006. 40:210-219. db*
    9. Swift-Scanlan T, Coughlin JM, Lan TH, Potash JB, Ashworth RG, DePaulo JR, Ross CA, McInnis MG. Characterization of CTG/CAG repeats on chromosome 18: A study of Bipolar disorder. Psychiatr Genet 2005; 15:91-9. db*
    10. Swift-Scanlan, T., Blackford A, Argani P, Sukumar S, and Fackler MJ. Two color Quantitative Multiplex Methylation Specific PCR. Biotechniques 2006. 40:210-219. db*
    11. Swift-Scanlan T., Coughlin JM, Lan TH, Potash JB, Ashworth RG, et al. Characterization of CTG/CAG repeats on chromosome 18: A study of bipolar disorder. Psychiatr Genet 2005. 15:91-99. db*
    12. Swift-Scanlan T., Lan TH, Fallin MD, Coughlin JM, Potash JB, et al. Genetic analysis of the (CTG)n NOTCH4 polymorphism in 65 multiplex bipolar pedigrees. Psychiatr Genet 2002; 12:43-47. db*
    13. McInnis MG, Swift-Scanlan T, Mahoney AT, Vincent J, Verheyen G, Lan TH, et al. Allelic distribution of CTG18.1 in Caucasian populations: association studies in bipolar disorder, schizophrenia, and ataxia. Mol Psychiatry 2000; 5:439-442. db
    14. Breschel TS, McInnis MG, Margolis RL, Sirugo G, Corneliussen B, Simpson SG et al. A novel, heritable, expanding CTG repeat in an intron of the SEF2-1 gene on chromosome 18q21.1. Hum Mol Genet 1997; 6:1855-1863. db*